Aviva (LON:AV – Free Report) had its price target lifted by JPMorgan Chase & Co. from GBX 615 ($7.93) to GBX 635 ($8.18) in a research report sent to investors on Thursday, Marketbeat.com reports. They currently have an overweight rating on the stock.
Separately, Deutsche Bank Aktiengesellschaft reissued a “top pick” rating on shares of Aviva in a research note on Friday, December 6th. Four research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of GBX 585.67 ($7.55).
Check Out Our Latest Report on AV
Aviva Stock Performance
Aviva (LON:AV – Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The company reported GBX 23.60 ($0.30) earnings per share (EPS) for the quarter. Aviva had a net margin of 3.52% and a return on equity of 14.82%. As a group, research analysts predict that Aviva will post 46.4942529 EPS for the current fiscal year.
Insider Activity at Aviva
In related news, insider Pippa Lambert purchased 988 shares of the company’s stock in a transaction that occurred on Friday, December 27th. The stock was purchased at an average price of GBX 465 ($5.99) per share, with a total value of £4,594.20 ($5,920.36). Insiders own 0.17% of the company’s stock.
About Aviva
Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products.
See Also
- Five stocks we like better than Aviva
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- P/E Ratio Calculation: How to Assess Stocks
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- 3 Warren Buffett Stocks to Buy Now
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for Aviva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aviva and related companies with MarketBeat.com's FREE daily email newsletter.